1.Diversidad de los viromas de mosquitos en diferentes nichos ecológicos.
2.Caracterización de la amplitud de la respuesta de anticuerpos neutralizantes hacia variantes emergentes de SARS-CoV-2.
3.Serología de alfavirus emergentes y reemergentes en México.

Publicaciones

1. Goldberg SA, Lu S, Garcia-Knight M, et al. Viral Determinants of Acute COVID-19 Symptoms in a Nonhospitalized Adult Population in the Pre-Omicron Era. Open Forum Infect Dis. 2023 Jul 24;10(8):ofad396. doi: 10.1093ofidofad396. F.I. 4.2
2. Arts PJ, Kelly JD, Midgley CM, Anglin K, Lu S, Abedi GR, Andino R, Bakker KM, Banman B, Boehm AB, Briggs-Hagen M, Brouwer AF, Davidson MC, Eisenberg MC, Garcia-Knight M, et al. Longitudinal and quantitative fecal shedding dynamics of SARS-CoV-2, pepper mild mottle virus, and crAssphage. mSphere. 2023 Aug 24;8(4):e0013223. doi: 10.1128msphere.00132-23. F.I. 5.0
3. Deyoe JE, Kelly JD, Grijalva CG, Bonenfant G, Lu S, Anglin K, Garcia-Knight M, et al. Association of culturable-virus detection and household transmission of SARS-CoV-2 - California and Tennessee, 2020-2022. J Infect Dis. 2023 Jan 27:jiad018. doi: 10.1093infdisjiad018. F.I. 6.4
4. Yang J, Xiao Y, Lidsky PV, Wu CT, Bonser LR, Peng S, Garcia-Knight MA, Tassetto M, Chung CI, Li X, Nakayama T, Lee IT, Nayak JV, Ghias K, Hargett KL, Shoichet BK, Erle DJ, Jackson PK, Andino R, Shu X. Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2. Nat Microbiol. 2023 Jan;8(1):121-134. doi: 10.1038s41564-022-01288-5. F.I. 30.9
5. Wu CT, Lidsky PV, Xiao Y, Cheng R, Lee IT, Nakayama T, Jiang S, He W, Demeter J, Knight MG, Turn RE, Rojas-Hernandez LS, Ye C, Chiem K, Shon J, Martinez-Sobrido L, Bertozzi CR, Nolan GP, Nayak JV, Milla C, Andino R, Jackson PK. SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming. Cell. 2023 Jan 5;186(1):112-130.e20. doi: 10.1016j.cell.2022.11.030. F.I. 66.9
6. Brazer N, Morris MK, Servellita V, Anglin K, Saldhi P, Garcia-Knight M, et al. Neutralizing immunity induced against the Omicron BA.1 and BA.2 variants in vaccine breakthrough infections. J Infect Dis. 2022 Sep 22:jiac384 doi: 10.1093infdisjiac384. F.I. 6.4
7. Mathur S, Davidson MC, Anglin K, Lu S, Goldberg SA, Garcia-Knight M, et al. Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in the Blood as a Diagnostic Test for Infection and Infectious Viral Shedding. Open Forum Infectious Diseases, 9:11, Nov 2022. doi: 10.1093ofidofac563. F.I. 4.2
8. Tassetto M*, Garcia-Knight M*, Anglin K*, Lu S*, et al. Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA.1 Sublineage Compared with Pre-Omicron Variant Specimens - San Francisco Bay Area, California, July 2021-March 2022. MMWR Morb Mortal Wkly Rep. 2022 Sep 9;71(36):1151-1154.*Equal contributions. doi: 10.15585mmwr.mm7136a3. F.I. 33.9
9. Kelly JD, Lu S, Anglin K, Garcia-Knight M, Pineda-Ramirez J, et. al. Magnitude and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission: A Longitudinal Cohort Study. Clin Infect Dis. 2022 Oct 3;75:S193-S204. doi: 10.1093cidciac545. F.I. 20.1
10. Garcia-Knight M, Anglin K*, Tassetto M*, Lu S, et. al. Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study. PLoS Pathog. 2022 Sep 12;18(9):e1010802. .*Equal contributions. doi: 10.1371journal.ppat.1010802. F.I. 6.7
11. Suryawanshi, R. K., Chen, I. P., Ma, T., Syed, A. M., Simoneau, C. R., Ciling, A., Khalid, M. M., Bharath S., Chen, P., George, A. F., Kumar, R., Montano, M., Garcia-Knight, M. A., et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature. 2022 Jul;607(7918):351-355. doi: 10.1038s41586-022-04865-0. F.I. 64.8
12. Servellita, V., Abdullah M. S., Morris, M. K., Brazer, N., Saldhi, P., Garcia-Knight, M. Sreekumar, B. Mir M. Khalid, et al. Neutralizing Immunity in Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron and Delta Variants. Cell. 2022 Apr 28;185(9):1539-1548.e5. doi: 10.1016j.cell.2022.03.019. F.I. 66.9
13. Li, X., Lidsky, P. V., Xiao, Y., Wu, C. T., Garcia-Knight, M., et al. Ethacridine inhibits SARS-CoV-2 by inactivating viral particles. PLoS Pathogens, 2021, 17(9), e1009898 doi: 10.1371journal.ppat.1009898. F.I. 6.7
14. Deng X*, Garcia-Knight MA*, Khalid MM*, et al. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant. Cell. 2021 Jun 24;184(13):3426-3437.e8. *Equal contributions. doi: 10.1016j.cell.2021.04.025. F.I. 66.9
15. Chen RE, Winkler ES, Case JB, Aziati ID, Bricker TL, Joshi A, Darling TL, Ying B, Errico JM, Shrihari S, VanBlargan LA, Xie X, Gilchuk P, Zost SJ, Droit L, Liu Z, Stumpf S, Wang D, Handley SA, Stine WB Jr, Shi PY, Davis-Gardner ME, Suthar MS, Knight MG, et al. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 Aug;596(7870):103-108. DOI: 10.1038s41586-021-03720-y F.I. 64.8
16. Samuel RM, Majd H, Richter MN, Ghazizadeh Z, Zekavat SM, Navickas A, Ramirez JT, Asgharian H, Simoneau CR, Bonser LR, Koh KD, Garcia-Knight M, et al. Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men. Cell Stem Cell. 2020 Dec 3;27(6):876-889. doi: 10.1016j.stem.2020.11.009. F.I. 23.9
17. Tassetto M, Kunitomi M, Whitfield ZJ, Dolan P, Sánchez-Vargas I, Garcia Knight M, et al. Control of RNA viruses in mosquito cells through the acquisition of vDNA and endogenous viral elements. eLife 2019;8:e41244 doi: 10.7554eLife.41244. doi: 10.7554eLife.41244. I.F. 8.7

Circuito de Posgrado, Ciudad Universitaria
Alcaldía Coyoacán, C.P. 04510, México, CDMX

55 5623 7006
mdcbq@posgrado.unam.mx